List of Studies ( Metabolite:Olmesartan)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST000923 | AN001515 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Feces | Human | Inflammatory bowel disease | The Broad Institute | Abundance |
ST003327 | AN005451 | Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics | Blood | Human | Trauma | University of Colorado Anschutz Medical Campus | area under curve |
ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
ST002711 | AN004394 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: biogenic amines | Blood | Human | Autism | Columbia University | normalized peak heights |
ST002498 | AN004656 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST000899 | AN001464 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
ST002088 | AN003408 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |